Literature DB >> 36073219

[Centromere protein U is highly expressed in colorectal cancer and associated with a poor long-term prognosis].

X Zhang1,2, Z Yang3, Q Hu4, L Zuo3, X Song2, Z Geng2, J Li1, Y Wang1, S Ge3, J Hu1.   

Abstract

OBJECTIVE: To analyze the expression of centromere protein U (CENPU) in colorectal cancer and its predictive value for long-term prognosis of the patients.
METHODS: We retrospectively analyzed the data of 102 patients with colorectal cancer undergoing radical resection in our hospital between January, 2005 and December, 2011. The expression level of CENPU in colorectal cancer tissue was detected immunohistochemically, and its association with clinicopathological characteristics of the patients were analyzed. The patients were divided into low expression group (n=51) and high expression group (n=51) based on the median CENPU expression level for analysis the value of CENPU for predicting long-term prognosis of the patients after radical resection of the tumors. In the in vitro study, we constructed colorectal cancer cell lines with CENPU interference and CENPU overexpression by lentiviral transfection and assessed the changes in the proliferation, migration and invasion of the cells using CCK-8 assay and Transwell assay.
RESULTS: The protein expression level of CENPU was significantly higher in colorectal cancer tissues than in the adjacent tissues (P < 0.05) and was positively correlated with the expressions levels of Ki67 (r=0.569, P < 0.05) and VEGF-C (r=0.629, P < 0.05). CENPU expression level in colorectal cancer tissue was closely related with tumor progression and clinicopathological stage of the tumor (P < 0.05). Kaplan-Meier survival analysis showed that the patients with high CENPU expression had significantly decreased postoperative overall survival (χ2=11.155, P < 0.05); Cox multivariate regression analysis suggested that CENPU expression level was an independent risk factor affecting the overall survival of the patients after radical resection (HR=1.848, P < 0.05). The results of cell experiments demonstrated that high CENPU expression significantly promoted the proliferation, migration and invasion of the tumor cells.
CONCLUSION: CENPU is highly expressed in colorectal cancer tissues in closely correlation with tumor progression and may serve as a potential biomarker for evaluating the long-term prognosis of colorectal cancer patients.

Entities:  

Keywords:  CENPU; clinicopathological parameters; colorectal cancer; risk factor analysis; survival analysis

Mesh:

Year:  2022        PMID: 36073219      PMCID: PMC9458528          DOI: 10.12122/j.issn.1673-4254.2022.08.12

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  27 in total

Review 1.  P53 mutations in colorectal cancer - molecular pathogenesis and pharmacological reactivation.

Authors:  Xiao-Lan Li; Jianbiao Zhou; Zhi-Rong Chen; Wee-Joo Chng
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

2.  LINC01605 regulates proliferation, migration and invasion of colorectal cancer cells via targeting miR-3960/SOX11.

Authors:  S-S Hu; L Fu; S-Y Han; X-L Li; L-D Zhang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2021-02       Impact factor: 3.507

Review 3.  Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery.

Authors:  Yan Ni; Guoxiang Xie; Wei Jia
Journal:  J Proteome Res       Date:  2014-08-14       Impact factor: 4.466

4.  Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.

Authors:  Hirotaka Horiguchi; Shingo Hatakeyama; Tohru Yoneyama; Mihoko Sutoh Yoneyama; Toshikazu Tanaka; Naoki Fujita; Teppei Okamoto; Hayato Yamamoto; Takahiro Yoneyama; Tadashi Yoshizawa; Yasuhiro Hashimoto; Toshiaki Kawaguchi; Chikara Ohyama
Journal:  Urol Oncol       Date:  2020-12-08       Impact factor: 3.498

Review 5.  Colorectal cancer development and advances in screening.

Authors:  Karen Simon
Journal:  Clin Interv Aging       Date:  2016-07-19       Impact factor: 4.458

6.  circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer.

Authors:  Yao Kong; Yuting Li; Yuming Luo; Jiang Zhu; Hanhao Zheng; Bowen Gao; Xiaofeng Guo; Zhihua Li; Rufu Chen; Changhao Chen
Journal:  Mol Cancer       Date:  2020-05-04       Impact factor: 27.401

Review 7.  Colorectal Cancer Immunotherapy: Options and Strategies.

Authors:  Nor Adzimah Johdi; Nur Fazilah Sukor
Journal:  Front Immunol       Date:  2020-09-18       Impact factor: 7.561

Review 8.  Genetic and biological hallmarks of colorectal cancer.

Authors:  Jiexi Li; Xingdi Ma; Deepavali Chakravarti; Shabnam Shalapour; Ronald A DePinho
Journal:  Genes Dev       Date:  2021-06       Impact factor: 11.361

Review 9.  The role of the VEGF-C/VEGFRs axis in tumor progression and therapy.

Authors:  Jui-Chieh Chen; Yi-Wen Chang; Chih-Chen Hong; Yang-Hao Yu; Jen-Liang Su
Journal:  Int J Mol Sci       Date:  2012-12-20       Impact factor: 5.923

10.  BUB1 and CENP-U, Primed by CDK1, Are the Main PLK1 Kinetochore Receptors in Mitosis.

Authors:  Priyanka Singh; Marion E Pesenti; Stefano Maffini; Sara Carmignani; Marius Hedtfeld; Arsen Petrovic; Anupallavi Srinivasamani; Tanja Bange; Andrea Musacchio
Journal:  Mol Cell       Date:  2020-11-27       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.